Pharma & Biotech
Exceptional track record – IPOs and Fundraisings.

£300 million ABV V fundraising (2007)

23 million Private placement (2005) 30 million IPO (OSE - 2007)

63 million IPO (SWX - 2005)

£8.2 million IPO (AIM - 2005) £7.75 million placing (AIM - 2006)

£40 million IPO (AIM - 2006)

7.5 million IPO (Alternext - 2005) 13 million secondary offering

£35 million IPO (LSE - 2004)

60 million IPO (Euronext Paris - 2007)

£880 million IPO (LSE/Moscow 2007)

$15 million PIPE (2005)

CHF88.5 million IPO (SWX - 2006)

35 million IPO (Euronext Belgium - 2006) 23.9 million secondary offering

30 million IPO (CSE - 2005)

£10.4 million placing (AIM - 2006)

$200 million IPO (Prague/LSE - 2004)




